Treatment News : Access to Meds to Treat Drug Addiction Is Vastly Limited

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » June 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

June 25, 2013

Access to Meds to Treat Drug Addiction Is Vastly Limited

Because of restrictions of Medicaid programs and insurance companies, medications to treat addiction to opiates are often inaccessible to those who need them, MedPage Today reports. The American Society of Addiction Medicine (ASAM) released a 216-page report on this issue, which is critical to the HIV epidemic because injection drug use is a major contributing factor to the virus’s spread. (Heroin, for example, is an opiate.)

The report found that access to these prescription treatments varies widely between state Medicaid programs, with just 28 covering all three of the medications Probuphine (buprenorphine), methadone and Vivitrol (naltrexone); all are approved by the U.S. Food and Drug Administration (FDA). Forty-two state Medicaid programs require prior authorization for buprenorphine. Many of the programs also impose coverage limits for lifetime benefits.

The report finds that there are similar restrictions on treatment coverage among private insurance companies and that coverage is sparse for such drugs as Suboxone (buprenorphine/naloxone) and injectable naltrexone.

Congress also imposes limits on the number of patients a clinician can treat at one time. Furthermore, the Drug Addiction Treatment Act of 2000 requires that care providers obtain a special Drug Enforcement Administration waiver to prescribe certain drugs to treat opioid addiction.

To read the MedPage Today report, click here.

To read the ASAM report, click here.

Search: Opiate, addiction, treatment, Medicaid, private insurer, American Society of Addiction Medicine, ASAM, Probuphine, buprenorphine, methadone, Vivitrol, naltrexone, buprenorphine, Suboxone, naloxone, Drug Addiction Treatment Act of 2000.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    fokisi
    Long Beach
    California


    InDefaultOf
    Seattle
    Washington


    latinpozdallas
    Dallas
    Texas


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.